The characteristic of an abnormal p-wave axis in patients with atrial fibrillation

J Electrocardiol. 2022 Jul-Aug:73:1-7. doi: 10.1016/j.jelectrocard.2022.04.003. Epub 2022 Apr 26.

Abstract

Backgrounds: An adverse increased risk of atrial fibrillation (AF) can be detected by measuring the p-wave indices, including prolonged p-wave duration, the PR interval, abnormal p-wave terminal force, and abnormal p-wave axis (aPWA). Our purpose was to characterize the AF patient population with an aPWA and to identify whether the aPWA was associated with recurrence after catheter ablation of AF.

Methods: This study retrospectively included 249 patients with AF who underwent catheter ablation in our hospital from October 2015 to May 2019. We measured the p-wave indices and left atrial cavity size (LAVI) before the catheter ablation. A logistic regression analysis was performed to analyze the concurrent effects of various factors on the prevalence of AF recurrence over 12 months after the ablation.

Results: An aPWA was observed in 35 patients (14%). There were significantly more patients with an aPWA in the non-PAF than PAF patients (26% versus 7%, p < 0.001). The patients with an aPWA had a significantly larger LAVI values (37 ± 12 versus 45 ± 11 ml/m2, p = 0.016). In a multivariate analysis, an aPWA (odds ratio, 4.27; 95% confidence interval, 1.75-10.4; p = 0.001) and the LAVI (odds ratio, 1.04; 95% confidence interval, 1.00-1.08; p = 0.032) were independently associated with recurrence after catheter ablation.

Conclusions: Our results demonstrated that measuring the aPWA in patients with atrial fibrillation before ablation was useful for identifying patients at a higher risk of recurrence after catheter ablation of AF.

Keywords: Atrial fibrillation; Catheter ablation; p-wave axis; p-wave indices.

MeSH terms

  • Atrial Fibrillation*
  • Catheter Ablation* / methods
  • Electrocardiography
  • Humans
  • Recurrence
  • Retrospective Studies
  • Treatment Outcome